<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">96688</article-id><article-id pub-id-type="doi">10.26442/20751753.2021.10.201089</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Interaction of drugs and coffee</article-title><trans-title-group xml:lang="ru"><trans-title>Взаимодействие лекарственных средств и кофе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7168-3636</contrib-id><name-alternatives><name xml:lang="en"><surname>Pereverzev</surname><given-names>Anton P.</given-names></name><name xml:lang="ru"><surname>Переверзев</surname><given-names>Антон Павлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Russian Medical Academy of Continuous Professional Education</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доц. каф. терапии и полиморбидной патологии ФГБОУ ДПО РМАНПО</p></bio><email>acchirurg@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0795-8225</contrib-id><name-alternatives><name xml:lang="en"><surname>Ostroumova</surname><given-names>Olga D.</given-names></name><name xml:lang="ru"><surname>Остроумова</surname><given-names>Ольга Дмитриевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Russian Medical Academy of Continuous Professional Education, Sechenov First Moscow State Medical University (Sechenov University)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф., зав. каф. терапии и полиморбидной патологии ФГБОУ ДПО РМАНПО, проф. каф. клин. фармакологии и пропедевтики внутренних болезней ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)</p></bio><email>ostroumova.olga@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Medical Academy of Continuous Professional Education</institution></aff><aff><institution xml:lang="ru">ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-10-15" publication-format="electronic"><day>15</day><month>10</month><year>2021</year></pub-date><volume>23</volume><issue>10</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>777</fpage><lpage>783</lpage><history><date date-type="received" iso-8601-date="2022-01-18"><day>18</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-01-18"><day>18</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/96688">https://consilium.orscience.ru/2075-1753/article/view/96688</self-uri><abstract xml:lang="en"><p>Coffee is the most widely consumed beverage in the world. About 80% of the world's population consumes coffee and other coffee products on a daily basis. For residents of Finland, Norway, Iceland and North America this figure reaches 90%. Coffee consists of a large number of chemical constituents, including caffeine, chlorogenic acids, diterpenes and trigonellins, which are the most biologically active and most important constituents of the beverage. Taking coffee together with drugs can affect their pharmacokinetic profile, changing the absorption process, the degree of dissolution, pH of the gastrointestinal tract (GIT), affecting the state of permeability of the membranes of the GIT cells, on the transit time of food through the GIT, as well as for due to the formation of insoluble complexes and inhibition of glucose-6-phosphatase. Coffee can reduce intestinal absorption of inorganic compounds (iron, calcium preparations), as well as some organic compounds (glucose, vitamin D, etc.) if taken simultaneously with coffee. Drinking large amounts of coffee due to active diuresis can also increase the elimination of electrolytes (including sodium, chlorides) and vitamins from the body. Another potential type of interaction between drugs and coffee is the pharmacodynamic type (at the level of receptors and pharmacological effects). For example, the instructions for the medical use of drugs – adrenergic receptor antagonists (for example, salbutamol, salmeterol, epinephrine) and methylxanthines (aminophylline, theophylline) contain information that the joint intake of coffee contributes to additional stimulation of the central nervous system and increases their toxicity. Healthcare practicionars should know and be sure to take into account the potential interactions between drugs and coffee and ensure an appropriate time interval between taking drugs and coffee, which will avoid the development of potential complications of pharmacotherapy.</p></abstract><trans-abstract xml:lang="ru"><p>Кофе – самый широко потребляемый напиток в мире. Около 80% населения мира принимают кофе и другие кофейные продукты ежедневно, а для жителей Финляндии, Норвегии, Исландии и Северной Америки данный показатель достигает 90% cлучаев. Кофе состоит из большого числа химических компонентов, в том числе кофеина, хлорогеновых кислот, дитерпенов и тригонеллинов, которые являются наиболее биологически активными и наиболее важными составляющими напитка. Прием кофе одновременно с лекарственными средствами (ЛС) может влиять на их фармакокинетический профиль, изменяя процесс абсорбции, степень растворения, уровень кислотности желудочно-кишечного тракта (ЖКТ), влияя на состояние проницаемости мембран клеток ЖКТ, на время транзита пищи по ЖКТ за счет образования нерастворимых комплексов и ингибирования глюкозо-6-фосфатазы. Кофе может снизить всасывание в кишечнике неорганических соединений, препаратов железа, кальция, а также некоторых органических соединений (глюкоза, витамин D и др.) в случае их одновременного приема с кофе. Употребление большого количества кофе за счет активного диуреза может также способствовать усилению выведения из организма электролитов (в том числе натрия, хлоридов) и витаминов. Еще одним потенциальным типом взаимодействия ЛС и кофе является фармакодинамический тип (на уровне рецепторов и фармакологических эффектов). Например, в инструкциях по медицинскому применению ЛС – антагонистов адренергических рецепторов (например, сальбутамол, салметерол, эпинефрин) и метилксантинов (аминофиллин, теофиллин) содержится информация о том, что совместный прием кофе способствует дополнительной стимуляции центральной нервной системы и усиливает их токсичность. Специалистам практического здравоохранения следует знать и обязательно учитывать потенциальные взаимодействия ЛС и кофе и обеспечить соответствующий временной промежуток между их приемом, что позволит избежать развития потенциальных осложнений фармакотерапии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>medicines</kwd><kwd>caffeine</kwd><kwd>unwanted reactions</kwd><kwd>drug-food interactions</kwd><kwd>coffee</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лекарственные средства</kwd><kwd>кофеин</kwd><kwd>нежелательные реакции</kwd><kwd>взаимодействия лекарство-пища</kwd><kwd>кофе</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Belayneh A, Molla F. The Effect of Coffee on Pharmacokinetic Properties of Drugs: A Review. Biomed Res Int. 2020;2020:7909703. DOI:10.1155/2020/7909703</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>WorldAtlas. The Top Coffee-Consuming Countries. Available at: https://www.worldatlas.com/articles/top-10-coffee-consuming-nations.html. Accessed: 12.08.2021.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Boekema PJ, Samsom M, van Henegouwen BGP, Smout AJ. Coffee and Gastrointestinal Function: Facts and Fiction: A Review. Scand J Gastroenterol Suppl. 1999;34(230):35-9. DOI:10.1080/003655299750025525</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Godos J, Pluchinotta FR, Marventano S, et al. Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr. 2014;65(8):925-36. DOI:10.3109/09637486.2014.940287</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Nuhu AA. Bioactive micronutrients in coffee: recent analytical approaches for characterization and quantification. ISRN Nutr. 2014;2014:384230. DOI:10.1155/2014/384230</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Goodman G. Goodman and Gilman's the Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 14th edition, 2012.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lippincott W, Wilkins M. Nutrition and Diagnosis-Related Care, 2008.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Krishna VN, Gouthami B, Meyyanathan SN, et al. In vitro In vivo pharmacokinetic interaction study of escitalopram oxalate when co administered with caffeine/caffeinated beverages. The Open Conference Proceedings Journal. 2013;4:66-71.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Liguori A, Hughes JR, Grass JA. Absorption and subjective effects of caffeine from coffee, cola and capsules. Pharmacol Biochem Behav. 1997;58(3):721-6. DOI:10.1016/s0091-3057(97)00003-8</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Cheeseman HJ, Neal MJ. Interaction of chlorpromazine with tea and coffee. Br J Clin Pharmacol. 1981;12(2):165-9. DOI:10.1111/j.1365-2125.1981.tb01196.x</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Aziba P, Isei M. The effect of caffeine on chlorpromazine induced catalepsy a parkinsonian sympton in rat. Biosciences Biotechnology Research Asia. 2012;9(2):689-93.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Morck TA, Lynch SR, Cook JD. Inhibition of food iron absorption by coffee. Am J Clin Nutr. 1983;37(3):416-20. DOI:10.1093/ajcn/37.3.416</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. DOI:10.1089/thy.2007.0222</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Wegrzyn NM. Malabsorption of L-T4 Due to Drip Coffee: A Case Report Using Predictors of Causation. J Acad Nutr Diet. 2016;116(7):1073-6. DOI:10.1016/j.jand.2016.02.016</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Meri R, Theresa G, Gerri F. Effects of caffeine and coffee on heartburn, acid reflux, ulcers and GERD. Available at: https://healthy.net/2019/01/06/effects-of-caffeine-and-coffee-on-heartburn-acid-reflux-ulcers-and-gerdreviewed-by-meri-rafetto-rd-theresa-grumet-rd-and-gerri-french-rd-ms-cde/. Accessed: 12.08.2021.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Edwards JE, Eliot L, Parkinson A, et al. Assessment of Pharmacokinetic Interactions Between Obeticholic Acid and Caffeine, Midazolam, Warfarin, Dextromethorphan, Omeprazole, Rosuvastatin, and Digoxin in Phase 1 Studies in Healthy Subjects. Adv Ther. 2017;34(9):2120-38. DOI:10.1007/s12325-017-0601-0</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yoovathaworn KC, Sriwatanakul K, Thithapandha A. Influence of caffeine on aspirin pharmacokinetics. Eur J Drug Metab Pharmacokinet. 1986;11(1):71-6. DOI:10.1007/BF03189777</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Craig CR, Stitzel RE. Modern Pharmacology with Clinical Applications, Lippincott Williams and Wilkins. 6th edition. LWW, 2003. Available at: https://www.amazon.com/Modern-Pharmacology-Clinical-Applications-Sixth/dp/0781737621. Accessed: 12.08.2021</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Babalola CP, Kolade YT, Adeyemo MA, et al. Effect of Caffeine-Containing Beverages on Physicochemical and Release Properties of Halofantrine. Global Journal of Medical Research. 2014;14(10):62-9.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Schmidt R, Fanchamps A. Effect of caffeine on intestinal absorption of ergotamine in man. Eur J Clin Pharmacol. 1974;7(3):213-6. DOI:10.1007/BF00560383</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Ngo M, Tadi P. Ergotamine/Caffeine. 2021. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Deleu D, Jacob P, Chand P, et al. Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease. Neurology. 2006;67(5):897-9. DOI:10.1212/01.wnl.0000233916.57415.9d</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Medina-López R, Vara-Gama N, Soria-Arteche O, et al. Pharmacokinetics and Pharmacodynamics of (S)-Ketoprofen Co-Administered with Caffeine: A Preclinical Study in Arthritic Rats. Pharmaceutics. 2018;10(1):20. DOI:10.3390/pharmaceutics10010020</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Myat TTW, Suprava D, Sherly DG, et al. Coffee Modify Pharmacokinetics of Acetaminophen. EC Pharmacology and Toxicology. 2019;7(10):1091-8.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Renner B, Clarke G, Grattan T, et al. Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J Clin Pharmacol. 2007;47(6):715-26. DOI:10.1177/0091270007299762</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. 2000;39(2):127-53. DOI:10.2165/00003088-200039020-00004</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Wojcicki J, Rainska-Giezek T, Gawronska-Szklarz B, Dutkiewicz-Serdynska G. Effects of caffeine on the pharmacokinetics of paracetamol. Acta Medica et Biologica. 1994;42(2):51-5.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Boekema PJ, Lo B, Samsom M, et al. The effect of coffee on gastric emptying and oro-caecal transit time. Eur J Clin Invest. 2000;30(2):129-34. DOI:10.1046/j.1365-2362.2000.00601.x</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Lipton RB, Diener HC, Robbins MS, et al. Caffeine in the management of patients with headache. J Headache Pain. 2017;18(1):107. DOI:10.1186/s10194-017-0806-2</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Bailey DG, Dresser GK, Urquhart BL, et al. Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With Felodipine. Am J Hypertens. 2016;29(12):1386-93. DOI:10.1093/ajh/hpw081</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Al-Othman A, Al-Musharaf S, Al-Daghri NM, et al. Tea and coffee consumption in relation to vitamin D and calcium levels in Saudi adolescents. Nutr J. 2012;11:56. DOI:10.1186/1475-2891-11-56</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Heaney RP. Effects of caffeine on bone and the calcium economy. Food Chem Toxicol. 2002;40(9):1263-70. DOI:10.1016/s0278-6915(02)00094-7</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Silva AT, Costa NMB, Franco FSC, Natali A. Calcium and caffeine interaction in increased calcium balance in ovariectomized rats. Revista de Nutrição. 2013;26(3):313-22. DOI:10.1590/S1415-52732013000300006</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr. 2001;74(5):694-700. DOI:10.1093/ajcn/74.5.694</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Kiel DP, Felson DT, Hannan MT, et al. Caffeine and the risk of hip fracture: the Framingham Study. Am J Epidemiol. 1990;132(4):675-84. DOI:10.1093/oxfordjournals.aje.a115709</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Hansen SA, Folsom AR, Kushi LH, Sellers TA. Association of fractures with caffeine and alcohol in postmenopausal women: the Iowa Women's Health Study. Public Health Nutr. 2000;3(3):253-61. DOI:10.1017/s136898000000029x</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Hernandez-Avila M, Colditz GA, Stampfer MJ, et al. Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women. Am J Clin Nutr. 1991;54(1):157-63. DOI:10.1093/ajcn/54.1.157</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Jokinen H, Pulkkinen P, Korpelainen J, et al. Risk factors for cervical and trochanteric hip fractures in elderly women: a population-based 10-year follow-up study. Calcif Tissue Int. 2010;87(1):44-51. DOI:10.1007/s00223-010-9382-z</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Meyer HE, Pedersen JI, Løken EB, Tverdal A. Dietary factors and the incidence of hip fracture in middle-aged Norwegians. A prospective study. Am J Epidemiol. 1997;145(2):117-23. DOI:10.1093/oxfordjournals.aje.a009082</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Nieves JW, Grisso JA, Kelsey JL. A case-control study of hip fracture: evaluation of selected dietary variables and teenage physical activity. Osteoporos Int. 1992;2(3):122-7. DOI:10.1007/BF01623818</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Ohnaka K, Ikeda M, Maki T, et al. Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial. J Nutr Metab. 2012;2012:207426. DOI:10.1155/2012/207426</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Welsch CA, Lachance PA, Wasserman BP. Dietary phenolic compounds: inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles. J Nutr. 1989;119(11):1698-704. DOI:10.1093/jn/119.11.1698</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Iqbal N, Ahmad B, Janbaz KH, et al. The effect of caffeine on the pharmacokinetics of acetaminophen in man. Biopharm Drug Dispos. 1995;16(6):481-7. DOI:10.1002/bdd.2510160606</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Chen X, Ghribi O, Geiger JD. Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis. 2010;20 Suppl. 1(Suppl. 1):S127-41. DOI:10.3233/JAD-2010-1376</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Chen X, Gawryluk JW, Wagener JF, et al. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation. 2008;5:12. DOI:10.1186/1742-2094-5-12</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Chen X, Lan X, Roche I, et al. Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem. 2008;107(4):1147-57. DOI:10.1111/j.1471-4159.2008.05697.x</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Tran A, Zhang CY, Cao C. The Role of Coffee in the Therapy of Parkinson’s Disease. J Alzheimers Dis Parkinsonism. 2015;5(3):2161-460. DOI:10.4172/2161-0460.1000203</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Deleu D, Jacob P, Chand P, et al. Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease. Neurology. 2006;67(5):897-9. DOI:10.1212/01.wnl.0000233916.57415.9d</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Информационный портал для специалистов практического здравоохранения Drug Bank. Режим доступа: https://go.drugbank.com/categories/DBCAT002609. Ссылка активна на 12.08.2021 [Drug Bank Information Portal for Practical Healthcare Professionals. Available at: https://go.drugbank.com/categories/DBCAT002609. Accessed: 12.08.2021 (in Russian)].</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Sohn OS, Surace A, Fiala ES, et al. Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica. 1994;24(2):119-27. DOI:10.3109/00498259409043226</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Ayalogu EO, Snelling J, Lewis DF, et al. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim Biophys Acta. 1995;1272(2):89-94. DOI:10.1016/0925-4439(95)00071-b</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Vaynshteyn D, Jeong H. Caffeine induces CYP1A2 expression in rat hepatocytes but not in human hepatocytes. Drug Metab Lett. 2012;6(2):116-9.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Djordjevic N, Ghotbi R, Jankovic S, Aklillu E. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2-163C&gt;A polymorphism. Eur J Clin Pharmacol. 2010;66(7):697-703. DOI:10.1007/s00228-010-0823-4</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Horn JR, Hansten PD. Caffeine and Clozapine. Pharmacy times. 2013. Available at: https://www.pharmacytimes.com/view/caffeine-and-clozapine. Accessed: 12.08.2021.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Hagg S, Spigset O, Mjörndal T, Dahlqvist R. Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. Br J Clin Pharmacol. 2000;49:59-63.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Zafar S, Ashraf MM, Ali A, et al. Effect of caffeine on anti-clotting activity of warfarin in healthy male albino rabbits. Pak J Pharm Sci. 2018;31(2 Suppl.):611-6.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Härtter S, Nordmark A, Rose DM, et al. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. Br J Clin Pharmacol. 2003;56(6):679-82. DOI:10.1046/j.1365-2125.2003.01933.x</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Cysneiros RM, Farkas D, Harmatz JS, et al. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther. 2007;82(1):54-62. DOI:10.1038/sj.clpt.6100211</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Zebothsen I, Kunze T, Clement B. Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes. Basic Clin Pharmacol Toxicol. 2006;99(1):37-43. DOI:10.1111/j.1742-7843.2006.pto_337.x</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Marx B, Scuvée É, Scuvée-Moreau J, et al. Mécanismes de l'effet diurétique de la caféine [Mechanisms of caffeine-induced diuresis]. Med Sci (Paris). 2016;32(5):485-90. DOI:10.1051/medsci/20163205015</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Zhang Y, Coca A, Casa DJ, et al. Caffeine and diuresis during rest and exercise: A meta-analysis. J Sci Med Sport. 2015;18(5):569-74. DOI:10.1016/j.jsams.2014.07.017</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Osswald H, Mühlbauer B, Schenk F. Adenosine mediates tubuloglomerular feedback response: an element of metabolic control of kidney function. Kidney Int Suppl. 1991;32:S128-31.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Massey LK, Whiting SJ. Caffeine, urinary calcium, calcium metabolism and bone. J Nutr. 1993;123(9):1611-4. DOI:10.1093/jn/123.9.1611</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Salema B, Ruivo J, de la Torre X, et al. Oxandrolone excretion: effect of caffeine dosing. Available at: http://www.adop.pt/media/4114/Oxandrolone_ excretion_effect_of_caffeine_dosing_.pdf. Accessed: 12.08.2021.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Avoid Food Drug Interactions. A Guide from the National Consumers League and 67. U.S. Food and Drug Administration: Food_and_Drug_Interactions. Available at: https://curehht.org/wp-content/uploads/2017/11/Food_and_Drug_Interactions_FDA.pdf. Accessed: 12.08.2021.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Государственный реестр лекарственных средств Минздрава России. Режим доступа: https://grls.rosminzdrav.ru. Ссылка активна на: 12.08.2021 [State Register of Medicines of the Ministry of Health of Russia. Available at: https://grls.rosminzdrav.ru. Accessed: 12.08.2021 (in Russian)].</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Jain G, Khar RK, Ahmad FJ. Theory and practice of physical pharmacy-e-book. Vol. 47, no. 1. Elsevier Health Sciences, 2013.</mixed-citation></ref></ref-list></back></article>
